A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilastDrug Design, Development and Therapy, 2013
- Properties of 7ND-CCL2 are modulated upon fusion to FcProtein Engineering, Design and Selection, 2012
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-β in fibroblast like synoviocytes of patients with RAExperimental & Molecular Medicine, 2007
- Misbehaving macrophages in the pathogenesis of psoriasisJournal of Clinical Investigation, 2006
- Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJournal of Clinical Investigation, 2006
- Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationJournal of Clinical Investigation, 2006
- Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibodyProtein Engineering, Design and Selection, 2006
- Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokinesJournal of Allergy and Clinical Immunology, 2001
- Allergen Specificity of Skin-Infiltrating T Cells Is Not Restricted to a Type-2 Cytokine Pattern in Chronic Skin Lesions of Atopic DermatitisJournal of Investigative Dermatology, 1996